Dermatology Practice EBITDA: What Counts and Why It Matters
Dermatology practice EBITDA is one of the most frequently discussed numbers in any sale, buy-in or financing conversation. It stands for earnings before interest, taxes, depreciation and amortization, and it is meant to show how much cash the business generates from operations before financing and accounting decisions.
This article explains what goes into the calculation, how adjustments work and why buyers and lenders look so closely at it. It is a definition and add-backs explainer rather than a valuation guide. Accounting treatment varies, and nothing here is tax, legal or accounting advice. Owners should work with an accountant.
What Is Dermatology Practice EBITDA?
The basic calculation starts with net income and adds back:
- Interest: the cost of debt, which depends on how the owner chose to finance the practice
- Taxes: which depend on the entity type and the owner’s situation
- Depreciation: the accounting expense for equipment and improvements
- Amortization: the accounting expense for intangible assets such as goodwill from a prior purchase
The goal is to compare operating performance across practices that have different debt, tax and asset histories.
Why Physician Compensation Matters So Much
In a physician-owned practice, the owner’s compensation is often the biggest variable. One owner may take a modest salary and large distributions; another may pay themselves almost everything as salary. Reported earnings can look very different even when the practices perform similarly.
For that reason, buyers usually normalize physician compensation. They replace what the owner actually took with what it would cost to pay a dermatologist to do the same clinical work. The result is sometimes called adjusted or normalized EBITDA, and it is often the figure that matters most in a transaction.
Common Add-Backs and Adjustments
Adjustments are meant to show what the practice would earn under a new owner. Examples sellers often propose include:
- Owner compensation above or below a market rate
- Personal expenses run through the practice, such as vehicles or travel
- One-time costs, such as a legal matter or a relocation
- Family members on payroll who will not stay after the sale
- Rent paid to an owner-controlled entity that differs from market rent
Every add-back should be documented. Buyers and lenders will test each one, and unsupported adjustments may be rejected.
What Buyers Look For
Buyers want to know whether dermatology practice EBITDA is durable. They often examine:
- Revenue mix: the balance of medical, surgical and cosmetic revenue
- Ancillary services: such as Mohs surgery, pathology and other in-house services
- Provider dependence: how much earnings rely on one physician
- Trends: whether earnings are rising, flat or falling
- Capital needs: equipment that will need replacing soon
Our guide to valuing a dermatology practice based on revenue and profit explains how earnings feed into valuation. Owners looking at profitability more broadly can read how profitable a dermatology practice can be.
Why Lenders Care
Lenders use earnings to estimate how much debt a practice can support. They generally look at cash available for debt service after a reasonable owner salary, and they may make their own adjustments rather than accepting the seller’s figures.
For larger transactions, such as multi-site groups or platform acquisitions, lenders may rely heavily on EBITDA-based analysis. Our middle-market healthcare financing page describes options for larger deals. Every loan is subject to lender review and approval.
EBITDA in Private Equity Transactions
Private equity groups often discuss price in terms of EBITDA. In these deals, the post-sale compensation arrangement for the selling physician directly affects the earnings figure the buyer is paying for. Sellers may accept lower future compensation in exchange for a higher price today, and part of the price may be paid in equity.
Our article on dermatology equity rollover explains how that equity component may work. Sellers should review these arrangements carefully with healthcare counsel and accountants.
EBITDA Is Not Cash Flow
EBITDA ignores some real cash needs. A practice still has to pay for equipment, taxes and debt. Two practices with similar earnings can differ greatly in how much cash is truly available to the owner. Buyers should look at capital spending, working capital needs and debt service alongside EBITDA.
Questions Buyers Should Ask About Reported Earnings
- Who prepared the financial statements, and are they consistent from year to year?
- Which add-backs are documented with invoices, payroll records or contracts?
- What compensation will the selling physician receive after closing, if any?
- Are any providers likely to leave, and how much of the earnings do they produce?
- Are there pending equipment purchases, lease increases or staffing changes?
Answers to these questions help a buyer judge whether the earnings presented will hold up under new ownership.
How Owners Can Improve the Picture Before a Sale
- Keep personal and business expenses separate
- Work with an accountant to prepare consistent financial statements
- Document any add-backs as they occur
- Reduce dependence on a single provider
- Address deferred equipment needs or be ready to explain them
Our guide on how to prepare a dermatology practice for sale covers these steps in more detail, and our advisory and consulting services can help owners review their numbers before going to market.
Final Thoughts
Dermatology practice EBITDA is a starting point, not a final answer. How compensation is normalized, which add-backs are supported and how durable the earnings appear all shape what buyers will pay and what lenders will finance. Understanding the calculation helps owners and buyers have more productive conversations.
US Medical Funding helps dermatologists finance acquisitions, buy-ins and partner buyouts based on a clear understanding of practice earnings. Learn more about our dermatology practice financing options.
